CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −44,300 | $25.42 | $1.1M | 6,722,631 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −900 | $321.72 | $290K | 12,175 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −3,062 | $322.93 | $989K | 9,113 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −2,023 | $323.63 | $655K | 7,090 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −885 | $325.01 | $288K | 6,205 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −3,015 | $326.28 | $984K | 3,190 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −2,290 | $327.22 | $749K | 900 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −700 | $328.07 | $230K | 200 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −100 | $329.41 | $33K | 100 |
| 2021-07-06 | OYLER JOHN Chief Executive Officer | Sale | −100 | $332.26 | $33K | 0 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −400 | $321.46 | $129K | 9,780 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −2,256 | $323.15 | $729K | 7,524 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −1,600 | $323.76 | $518K | 5,924 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −2,114 | $326.30 | $690K | 3,810 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −2,610 | $327.26 | $854K | 1,200 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −1,000 | $328.19 | $328K | 200 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −100 | $329.60 | $33K | 100 |
| 2021-07-06 | Wu Xiaobin President, COO & GM China | Sale | −100 | $331.88 | $33K | 0 |
| 2021-07-01 | Wang Xiaodong Director | Sale | −300 | $342.68 | $103K | 4,548 |
| 2021-07-01 | Wang Xiaodong Director | Sale | −437 | $345.88 | $151K | 4,111 |
Page 67 of 99 · 1,972 trades